Archives

by in
Entry Author Date Location
Trius Chops IPO Price, Offers More Shares 08/02/10 San Diego
Optimer Seeks EU Approval 07/29/10 San Diego
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
Trius IPO Plans Back on Track 07/15/10 San Diego
$4.5M for Excelimmune 07/07/10 Boston
Trius Gets FDA Clarity 06/16/10 San Diego
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News 06/04/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
Trius Gets $29.5M Defense Contract 05/20/10 San Diego
Clinical Data Seeks to Challenge Lilly, Pfizer in Antidepressant Market 05/11/10 Boston
Optimer Hires New CEO 05/06/10 San Diego
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer 04/20/10 San Diego
Frazier, Arch Join $56M Antibiotic Deal 04/07/10 Seattle
Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company 03/23/10 Boston
Trius Puts the Brakes on IPO Plan, While It Adjusts to New FDA Clinical Guidelines 03/05/10 San Diego
Optimer Nets $51.5M 03/01/10 San Diego
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy 02/16/10 Boston
Halozyme Pursues Anti-Cellulite Drug, Optimer’s Antibiotic Kills C. Difficile Germs, Tragara Pharmaceuticals Raises Funds & More San Diego Life Sciences News 02/11/10 San Diego
Optimer Rises on Takeover Buzz and Clinical Trial Results; Still Faces Business Risks 02/08/10 San Diego
Optimer Passes Second Big Trial of Drug for Deadly Bacteria 02/04/10 San Diego
Cubist Maintains Growth Streak, As Investors Fear Generic Threat, Thin Pipeline 01/25/10 Boston
Novexel Offers Exit to Atlas and Abingworth 12/24/09 Boston
Cubist to Acquire Calixa Therapeutics in Deal Worth up to $402.5M 12/14/09 Boston
Trius Therapeutics Reveals Plans for IPO, SpectraScience Raises $4.3M, Sequenom Tightens its Belt, & More San Diego Life Sciences News 11/12/09 San Diego
Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner 08/05/09 Boston
Trius Approaches Next Stage in Drug Development, China Partnerships a Hot Topic at CalAsia, Lpath Headed to Critical Juncture, & More San Diego Life Sciences News 06/18/09 San Diego
Trius Looks to Cut a Deal, Gears Up For Final Stage of Trials with New Antibiotic 06/12/09 San Diego
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News 06/11/09 San Diego
Trius, Developer of Antibiotic for Deadly MRSA Bacteria, Passes Key Test 06/08/09 San Diego
Optimer Rides Investment See-Saw With Promising Drug for “C.diff” Infections 06/05/09 San Diego
Page 3 of 4 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Automatic's App Puts Your Smartphone in Charge of Your Car

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.